Showing results (161-170 of 188) with videos related to
Sort By:
Pageof 19
The Journal of Pathology. Clinical Research|January 21, 2026
AI for pathologists: a universal lymph node metastasis detection app that enhances efficiency while preserving diagnostic accuracyJennifer Vazzano, Bindu Challa, Vidya Arole, et al.Research Square|May 19, 2023
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activityChandra Bhushan Prasad, Adrian Oo, Zhaojun Qiu, et al.Archives of Pathology & Laboratory Medicine|March 17, 2017
False-Negative Interpretation of Adenocarcinoma In Situ in the College of American Pathologists Gynecologic PAP Education ProgramChengquan Zhao, Barbara A Crothers, Z Laura Tabatabai, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Clinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional StudyThaer Khoury, Marilin Rosa, Anupma Nayak, et al.Pathology, Research and Practice|October 12, 2023
Comparison of four different displays for identification of select pathologic features extracted from whole slide images of surgical pathology casesNada Shaker, Konstantin Shilo, Ashwini K Esnakula, et al.American Journal of Clinical Pathology|May 25, 2025
Endoscopic ultrasound-guided pancreatic core-needle/microforceps biopsy is a valuable diagnostic tool for pancreatic lesions: Experience from a large academic institutionSaba Shafi, Wendy L Frankel, Zaibo Li, et al.Cancer Letters|July 10, 2024
PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancerDeepika Singh, Zhaojun Qiu, Spehar M Jonathan, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 15, 2020
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional studyRohit Bhargava, Nicole N Esposito, Siobhan M OʹConnor, et al.Nature Communications|May 31, 2024
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activityChandra Bhushan Prasad, Adrian Oo, Yujie Liu, et al.Cancer Research|June 12, 2020
A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 InhibitorsZhaojun Qiu, Pengyan Fa, Tao Liu, et al.Pageof 19